Literature DB >> 20430697

What can we learn from an unnatural immune response?

Brandy Lee Bennett1, Photini Sinnis.   

Abstract

In a recent review on CD8+ T-cell responses after malaria infection and immunization, Zavala and colleagues outline two decades of research and formulate the central unresolved questions in the field. Here we discuss some of these findings and highlight their importance to malaria vaccinology. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20430697      PMCID： PMC2900482          DOI： 10.1016/j.pt.2010.02.011

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN： 1471-4922


  25 in total

Review 1.  Effector and memory T-cell differentiation: implications for vaccine development.

Authors:  Susan M Kaech; E John Wherry; Raft Ahmed
Journal:  Nat Rev Immunol       Date:  2002-04       Impact factor: 53.106

Review 2.  Tolerogenic dendritic cells.

Authors:  Ralph M Steinman; Daniel Hawiger; Michel C Nussenzweig
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 3.  Field studies of cytotoxic T lymphocytes in malaria infections: implications for malaria vaccine development.

Authors:  M Aidoo; V Udhayakumar
Journal:  Parasitol Today       Date:  2000-02

4.  Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment.

Authors:  Elodie Belnoue; Fabio T M Costa; Tobias Frankenberg; Ana Margarida Vigário; Tatiana Voza; Nicolas Leroy; Mauricio M Rodrigues; Irène Landau; Georges Snounou; Laurent Rénia
Journal:  J Immunol       Date:  2004-02-15       Impact factor: 5.422

5.  Genetically modified Plasmodium parasites as a protective experimental malaria vaccine.

Authors:  Ann-Kristin Mueller; Mehdi Labaied; Stefan H I Kappe; Kai Matuschewski
Journal:  Nature       Date:  2004-12-05       Impact factor: 49.962

6.  Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites.

Authors:  Stephen L Hoffman; Lucy M L Goh; Thomas C Luke; Imogene Schneider; Thong P Le; Denise L Doolan; John Sacci; Patricia de la Vega; Megan Dowler; Chris Paul; Daniel M Gordon; Jose A Stoute; L W Preston Church; Martha Sedegah; D Gray Heppner; W Ripley Ballou; Thomas L Richie
Journal:  J Infect Dis       Date:  2002-04-01       Impact factor: 5.226

Review 7.  Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria.

Authors:  Stephen L Hoffman; Peter F Billingsley; Eric James; Adam Richman; Mark Loyevsky; Tao Li; Sumana Chakravarty; Anusha Gunasekera; Rana Chattopadhyay; Minglin Li; Richard Stafford; Adriana Ahumada; Judith E Epstein; Martha Sedegah; Sharina Reyes; Thomas L Richie; Kirsten E Lyke; Robert Edelman; Matthew B Laurens; Christopher V Plowe; B Kim Lee Sim
Journal:  Hum Vaccin       Date:  2010-01-21

8.  Quantitation of malaria sporozoites transmitted in vitro during salivation by wild Afrotropical Anopheles.

Authors:  J C Beier; F K Onyango; J K Koros; M Ramadhan; R Ogwang; R A Wirtz; D K Koech; C R Roberts
Journal:  Med Vet Entomol       Date:  1991-01       Impact factor: 2.739

9.  A high malaria reinfection rate in children and young adults living under a low entomological inoculation rate in a periurban area of Bamako, Mali.

Authors:  Issaka Sagara; Djibril Sangaré; Guimogo Dolo; Aldiouma Guindo; Mamady Sissoko; Moussa Sogoba; Mohamed B Niambélé; Daniel Yalcoué; David C Kaslow; Alassane Dicko; Amy D Klion; Dapa Diallo; Louis H Miller; Yeya Touré; Ogobara Doumbo
Journal:  Am J Trop Med Hyg       Date:  2002-03       Impact factor: 2.345

10.  Differential immunogenicity of various heterologous prime-boost vaccine regimens using DNA and viral vectors in healthy volunteers.

Authors:  Jenni M Vuola; Sheila Keating; Daniel P Webster; Tamara Berthoud; Susanna Dunachie; Sarah C Gilbert; Adrian V S Hill
Journal:  J Immunol       Date:  2005-01-01       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.